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Abstract
Background: Although there is trial evidence that complex interventions are effective for the self-management of
heart failure, little evidence supports their effectiveness in routine practice. We used Social Practice Theory to guide
a Type 1 Hybrid Trial: a mixed methods process evaluation of a complex intervention for heart failure. The objective
of this paper is to explore the value of Social Practice Theory for implementation science.
Methods: Social Practice Theory informed a mixed methods process evaluation of a multi-centre randomised
controlled trial of a 12 week home-based intervention to optimise self-care support for people with heart failure
and their caregivers - Rehabilitation EnAblement in Chronic Heart Failure (REACH-HF). Interviews were conducted
with 19 people with heart failure and 17 caregivers at 4 months and 12 months after recruitment into the trial.
Cases were constructed at the level of the individual, couple, facilitator and centre; and included multi-modal
process and outcome data. Evaluative coding and subsequent within- and cross-case analyses enabled the
development of a typology of relationships linking fidelity of intervention delivery and tailoring of content to
individual needs and concerns. Social Practice Theory was used to interrogate the relationships between elements
of the intervention and their implementation.
Results: Of 216 trial participants, 107 were randomised to the intervention (REACH-HF plus usual care). The
intervention was most effective when fidelity was high and delivery was tailored to the individual’s needs, but less
effective when both tailoring and fidelity were low. Theory-based analysis enabled us to model complex
relationships between intervention elements (competencies, materials and meanings) and social context. The
findings illustrate how intervention fidelity and tailoring are contextual and how the effectiveness of the REACH-HF
intervention depended on both optimal alignment and implementation of these elements.
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Conclusion: The study demonstrates the utility of theory-based analysis which integrates data from multiple
sources to highlight contexts and circumstances in which interventions work best. Social Practice Theory provides a
framework for guiding and analysing the processes by which a complex intervention is evaluated in a clinical trial,
and has the potential to guide context-specific implementation strategies for clinical practice.
Trial registration: ISRCTN, IISRCTN86234930. Registered 13th November 2014.
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Background
Although there is evidence that complex interventions
are effective for the self-management of heart failure,
many are not implemented in routine practice. Exercise
based cardiac rehabilitation in patients with heart failure
have shown improvements in health-related quality of
life and a reduction in hospitalisations [1]. Whilst evi-
dence for the added value of centre and group-based
cardiac rehabilitation for patients with heart failure is
strong, uncertainty remains about the effectiveness of al-
ternative modes of delivery [2].
Previous research has failed to describe the complexity
of living with heart failure and the burden of self-
management and adherence to intervention regimens
[3]; failed to identify elements which consistently im-
prove outcomes in self-management interventions for
people with heart failure [4]; and failed to explain how
programme elements of cardiac rehabilitation interven-
tions interact [5]. Systematic reviews of randomised con-
trolled trials for heart failure have also identified a lack
of process evaluations assessing change processes which
may inform wider implementation [6].
The Rehabilitation Enablement in Chronic Heart Fail-
ure (REACH-HF) multicentre randomised controlled
trial demonstrated the clinical effectiveness and cost-
effectiveness of the REACH-HF cardiac rehabilitation and
self-care intervention for patients with heart failure with
reduced ejection fraction (HFrEF) and their caregivers [1,
7, 8]. The randomised controlled trial subsequently dem-
onstrated a statistically significant and clinically meaning-
ful between-group (intervention-control) difference in the
Minnesota Living with Heart Failure Questionnaire
(MLHFQ) score of − 5.7 points (95% confidence interval
− 10.6 to − 0.7) in favour of the REACH-HF intervention
group (p = 0.025) at 12months (minimal clinically import-
ant difference (MCID) for MLFHQ is 5 points; a higher
score indicates a worse clinical outcome) [7].
In this paper we report the results of the theory-based
process evaluation and identify the extent to which So-
cial Practice Theory has the potential to progress our
understanding from a pragmatic trial of a clinical inter-
vention at T2 (translation to patients), to the develop-
ment of an intervention strategy for implementation at
T3 (translation to practice) [9, 10], e.g. via the identifica-
tion of configurations of intervention elements [11, 12].
While the MRC framework for process evaluations of
complex interventions remains a valuable tool for ex-
ploring mechanisms of impact, debates regarding the
role of mechanisms in complex interventions and adap-
tation to context remain unresolved [13]. Trialists have
previously called for greater theorising and understand-
ing of the social aspects of complex interventions [14–
16]. Paying attention to social context can improve the
effectiveness of interventions in a given context; promote
sustainability of an intervention in that context; and pro-
mote dissemination in other contexts [17, 18]. More spe-
cifically, self-management interventions for chronic
conditions could be considerably more effective if the
experiences, social and contextual interactions and
sense-making processes of both patients and health pro-
fessionals were prioritised in trial design, evaluation and
implementation.
Normalisation Process Theory (NPT) has provided a
mid-range theory to guide the implementation and
evaluation of complex interventions [19], but the endur-
ing gap between research and implementation suggests
that identification of other potential solutions is war-
ranted [20]. While the focus of the NPT framework is
on the work that professionals do to ensure that inter-
ventions become normalised, less attention has been
given to the identification and evaluation of the elements
that constitute the mechanisms of impact and how they
may or may not operate in a given context [21].
Braithwaite et al. argue that a linear pipeline model of
implementation demotes contextual characteristics to
‘confounders’, rather than viewing them as the normal
conditions of the practice of healthcare [22]. This per-
spective is supported by several authors, who have re-
ported on the proliferation of behaviour change
interventions that focus mainly on intra-individual pro-
cesses of change, while identifying that processes related
to social context have been overlooked [23, 24].
Social practice theory
One way to operationalise the evaluation of an interven-
tion ‘in context’ is via Social Practice Theory. This
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theory has proven popular in environmental research,
where it has identified the systemic failure of interven-
tions to change behaviour [25, 26]. In contrast to linear
models of implementation, Social Practice Theory offers
a more dynamic framework because, rather than focus-
ing on individuals or institutions or programme theories,
it is concerned with the implementation of ‘practice
bundles’ or sets of interconnected elements and the ways
in which practices are reproduced, maintained, stabi-
lised, challenged and surpassed [25, 27].
Social practice is constituted by interdependencies be-
tween diverse elements including bodily activities (e.g.
exercising), mental activities (e.g. undertaking cross-
words for relaxation), material objects (e.g. use of scales
for weighing) and their use, background knowledge (e.g.
from lay and professional carers) in the form of shared
understandings, states of emotion (e.g. anxiety) and mo-
tivational knowledge (e.g. the value of maintaining social
activities) [11]. Practices have 3 elements: 1) Materials
including technologies, tangible, physical entities, and
the stuff of which objects are made; 2) Competences
which encompasses skills, knowhow and techniques; and
3) Meanings which include symbolic or shared mean-
ings, social norms, ideas and collective aspirations. These
elements are the ‘building blocks of practice’, which
allow us to describe processes of transformation, diffu-
sion and circulation [11]. For practices to be sustainable
they need to capture and retain practitioners who are
willing and able to enact these integrating processes and
who are therefore willing and able to keep the practices
alive. The value of this approach is that it allows us to
map the uneven landscapes of opportunity and unequal
patterns of access between participants; enabling us to
identify the relatively privileged (with the physical, cog-
nitive or socio-economic means to engage), and the mar-
ginalised (i.e. the socially excluded who are lacking
opportunities to become ‘carriers of practice’) [28, 29].
Brief description of the REACH-HF trial
The aim of the Rehabilitation Enablement in Chronic
Heart Failure (REACH-HF) programme of research was
to develop and evaluate a 12-week, home-based facili-
tated heart failure manual to enhance the quality of life
and self-care of people with heart failure and their care-
givers (Table 1) [1]. The support needs of people with
heart failure and their caregivers were established, and
the REACH-HF intervention developed by an interven-
tion mapping process and feasibility study [31].
The REACH-HF randomised controlled trial was con-
ducted at 4 centres in the UK, and a theory-based
process evaluation undertaken to assess fidelity of deliv-
ery (using a checklist applied to recordings of facilitator-
patient-caregiver interactions), and to characterise pa-
tients’ and caregivers’ observed and self-reported
responses to the intervention [7, 32]. ‘The aim of this
paper is to use Social Practice Theory to identify mecha-
nisms through which the intervention did or did not
work, and consider the implications for subsequent im-
plementation in routine clinical practice.
Contributions to the literature
 We undertook a Type 1 Hybrid Trial (a randomised
controlled trial evaluating the effect of a complex
intervention for the self-management of heart fail-
ure, and simultaneously collected longitudinal
process data about how the intervention was imple-
mented) and used a rigorous mixed methods ap-
proach to explore data from multiple sources.
 Social Practice Theory was used to map and
interrogate the relationships between the various
elements (materials, competencies and meanings) of
the intervention and their implementation in a range
of clinical contexts over time.
 Social Practice Theory enabled us to identify that
the REACH-HF intervention was optimised when
the competencies of the facilitator and the interven-
tion materials were tailored to the goals and needs
of the participant in ways which enabled participants
to transform their meaning and develop sustainable
and flexible self-management practices - but only
where the magnitude of any complex problems were
within the scope of the intervention.
Table 1 REACH-HF components
The REACH-HF intervention consists of four components:
1 The intervention manual is intended to support people with heart
failure and their carers. It contains sections about the condition itself
and a range of self-management strategies including medication
management, wellbeing and a traffic light algorithm for appropriate
help seeking. The manual contains a choice of two structured
exercise programmes:
a) a chair-based exercise DVD with seven levels of progressively
increasing intensity;
b) a walking exercise programme aiming to improve the patient’s
fitness over time, by encouraging longer walks and a gradually
increasing pace, according to each person’s capacity
Some of the material from the Heart Manual has been developed
as self-help exercises and recorded on CD, to help people relax
and manage their breathing [30].
2 The Progress Tracker booklet is intended to encourage patients to
monitor their own activities. Regular use of the booklet is intended
to help people learn from their own experiences and develop a
better understanding of how self-management affects their
symptoms and wellbeing.
3 The Family and Friends Resource is a companion manual providing
information for carers, in relation to caring for the patient as well
as caring for themselves
4 Facilitators: A three day training course for facilitators promoted the
use of person-centred counselling, individual assessment and
tailoring of the REACH-HF intervention resources to the individual
needs of patients and their caregivers.
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 Our findings suggest that Social Practice Theory has
the potential to progress our understanding from a
trial of a clinical intervention at T2 (translation to
patients), to guide the development of intervention
strategies for implementation at T3 (translation to
practice) via the identification of the most
appropriate configurations of bundles of
intervention elements for implementation of
personalised interventions at scale.
Methods
Study design
We conducted a theory-based process evaluation of a
randomised controlled trial evaluating the effect of the
REACH-HF intervention for the self-management of
heart failure [1]. We employed a Hybrid Type 1 trial de-
sign which both tested the effectiveness of the evidence
based intervention and collected data on the implemen-
tation processes [12]. The methods of both the REACH-
HF randomised controlled trial and process evaluation
have been described in detail [7, 32].
Two hundred sixteen patients and 97 caregivers were
recruited to the randomised controlled trial from 4 geo-
graphical regions across the UK (Birmingham, Cornwall,
Gwent and York). One hundred seven patients were ran-
domised to the intervention arm of the trial, and 109 to
usual care. The sampling frame for the process evalu-
ation was the intervention arm of the randomised con-
trolled trial, from which 19 patients were sampled for
maximum variation in their baseline scores for the pri-
mary and secondary outcome measures of the trial: The
primary outcome was disease-specific health-related
quality of life at 12 months measured using the Minne-
sota Living with Heart Failure Questionnaire (MLHFQ)
[33]. Secondary outcomes were death, hospitalization,
generic quality of life (five-dimension EuroQol (EQ-5D-
5L) scale) [34], psychological wellbeing (Hospital Anx-
iety and Depression Scale (HADS)) [35], exercise cap-
acity (incremental shuttle walk test) [36] and physical
activity assessed using a GeneActiv accelerometer [37].
Additional secondary measures included the HeartQoL
questionnaire [38] and Self-Care of Heart Failure Index
[39]. At the baseline clinic visit sociodemographic data
and information on past medical history from primary
and secondary care records were collected, including
New York Heart Association classification [40], key co-
morbidities, concomitant cardiac drugs and presence of
implantable cardiac devices.
Data collection
Both patients and caregivers were contacted by the
interviewer and, with their consent, interviewed 4
months and 12 months after the baseline study enrol-
ment visit. Face to face or telephone interviews were
conducted by experienced qualitative researchers (JW,
LM) and, with participant consent, audio-recorded and
transcribed. A semi-structured interview schedule en-
abled the interviewers to explore existing self-care prac-
tices, perceptions of the interaction with the facilitator
and the extent to which different aspects of the interven-
tion were engaged with. As well as assessing behaviour
change, we also sought to explore contextual factors
which may have facilitated or inhibited change, and the
experience of living with progressive chronic heart fail-
ure more generally, and change over time.
For the 19 people with heart failure and 17 caregivers
who constituted our sampling frame (2–3 patients per
facilitator across the 4 regions), all face-to face meetings
with the facilitator (typically one 90 min and two to
three 45min), and subsequent telephone contacts (typic-
ally 3–6 per patient) were audio-recorded by the facilita-
tor. A 13-domain fidelity checklist was developed and
piloted during the feasibility study, and used in the
process evaluation to assess the facilitators’ delivery of
the intervention. The intervention designers (JW, CG)
applied the checklist to the audio recorded intervention
sessions [31]. Fidelity scoring attributed a numerical
value (0–6) for each of the 13 domains on the fidelity
checklist. A purposive sample of audio recordings were
used to identify examples of optimal and sub-optimal
delivery fidelity (chosen on the basis of maximum diver-
sity of fidelity scores between patients, and where dis-
sonance was identified by JW and CG). Ethical approval
was granted by the North West- Lancaster Research
Ethics Committee; the trial registration number is
ISRCTN86234930.
Data analysis
Multi-modal data from both the randomised controlled
trial and process evaluation were managed with Stata
v14.2 [41] and Nvivo 11 Pro [42] and assigned to cases
at four levels: all data for a patient/caregiver; dyads of
patients and caregivers; all data for each facilitator; and
each centre. Multi-modal cases were then created for
each patient/caregiver [43], including interview tran-
scripts, contact sheets, audio recordings of facilitator-
patient sessions and associated fidelity scores, summaries
of interactions, field notes, clinical data such as case-
report forms, and patient reported outcome measures.
Interview transcripts were subject to a preliminary
cycle of evaluative coding, which assigned a judgement
about the value or significance of the intervention [44].
This noted the presence or absence of an element (e.g.
chair based or walking exercise) and the extent to which
it was positively or negatively evaluated by the patient/
caregiver. This amplified the fidelity scores, which attrib-
uted a numerical value (0–6) to the facilitation as out-
lined in the facilitator training manual. A secondary
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cycle of explanatory coding extended the mapping of
variance across the dataset, and enabled within-case ana-
lyses over time, cross-case analyses of intervention ele-
ments and social and contextual variables [44], and the
further identification of directional processes [45]. Fidel-
ity was coded on the basis of the emphasis given to the
intended core components of the intervention, while tai-
loring was coded in relation to the spirit of the interven-
tion being adapted to the local context in order to
achieve a ‘good ecological fit’ [13].
Social Practice Theory was used to further interrogate
the relationships between the various elements of the
intervention [11]. While JF coded the data, the iterative
analysis was undertaken through extensive team discus-
sions with JW who had collected most of the data, pro-
duced extensive field notes, reviewed the transcripts and
assessed the audio-recorded facilitation sessions for fi-
delity, and NB who independently annotated the content
of purposively sampled facilitated sessions. Crucially, the
qualitative data collection and preliminary analysis was
completed before the overall trial outcome data were
known, to minimise bias in interpretation [16, 43]. Ana-
lysing the longitudinal data from all 19 cases over two
time-points [43, 45] enabled the development of a typ-
ology of relationships exploring fidelity of intervention
delivery and tailoring of content to individual needs and
concerns..
Results
Repeat semi-structured interviews were conducted with
19 patients (14 at 12 months) and 17 caregivers (15 at
12 months) between August 2015 and August 2016.
Baseline demographic and health characteristics of the
107 REACH-HF patient participants in the intervention
arm are set out in Table 2, with characteristics of the 19
interviewed participants shown for descriptive compari-
son. Data has been anonymised.
Our in-depth analysis of this multi-modal data en-
abled us to create a 2 × 2 typology of fidelity and tai-
loring [46]. Here we provide four in depth illustrative
cases (Table 3) that represent each of the possible
combinations of fidelity and tailoring, and which illu-
minate the strengths and weaknesses of the REACH-
HF intervention when viewed from a social practice
perspective. These cases were selected for comparative
purposes and each typifies one quadrant of the table, and
demonstrate the results of our theory-based analysis
(Table 4). High fidelity and good tailoring enabled facilita-
tors to improve patients’ competencies, develop appropri-
ate meanings and provide suitable materials. Conversely,
poor fidelity and/or poor tailoring meant that some or all
of patients’ competencies, meanings or materials were not
enhanced, particularly in situations of little social and ma-
terial capital. Not all cases were clear cut.
Good fidelity and good tailoring
Mary is a 74 year old woman, diagnosed with heart fail-
ure 3 years before the study, who lives with her husband
but is cared for by her three daughters. Mary received
the lowest ‘dose’ of REACH-HF in these examples (293
min, over three face-to-face and three telephone inter-
vention sessions). At the initial assessment, the facilitator
explored Mary’s current understanding of her situation
and baseline ‘capacity’ before gradually introducing the
REACH-HF manual. This is reflected in the high fidelity
scores at the initial intervention session (5 or more in 7
of the 13 domains) and subsequently (4–5 in most do-
mains). At the initial assessment, the facilitator linked
the discussion of Mary’s arthritis to her capacity for
walking before going on to talk about the exercise com-
ponent of the manual (e.g. the participant’s existing
meaning and competence, and trial materials). This as-
sessment was used to elicit Mary’s highest-priority self-
care goal (walking) and the work required to fulfil this.
The facilitator provided answers to Mary’s questions
(thus improving her competence), as well as providing
explicit instances of information to augment Mary’s un-
derstanding of her condition. The information provided
by the facilitator was reinforced with the tailored use of
the manual, which enabled Mary to create new under-
standing and meaning around her heart failure.
At 12 months Mary was clear that her enduring use of
the manual after the intervention period improved her
self-care. To sustain change over time, the facilitator
drew on Mary’s existing relationships with her heart fail-
ure specialist nurse (HFSN) and General Practitioner
(GP), and signposted her to their continued support. As
well as drawing on the competencies of other profes-
sionals, this skilled facilitator was also able to transform
family support, in response to Mary’s suggestion that
she was feeling stifled by her daughters. Subsequently
Mary’s daughters worked with the facilitator and the
Friends and Family resource to support Mary in reach-
ing her goals. Mary’s daughter annotated the Progress
Tracker with stickers to help navigate key tasks, as well
as developing a one-page tailored ‘tracker’ for Mary to
write down her exercise, signs and symptoms, relaxation
activities and sleep pattern after the intervention period.
This enabled Mary to continue learning and develop her
new found autonomy as her walking and confidence
improved.
By using the initial assessment session to take a com-
prehensive medical history and explore Mary’s goals, this
facilitator was able to use her time most efficiently and
tailor the intervention to Mary’s needs. The facilitator
also engaged her social support network to involve a
series of others in working with Mary to achieve her goal
and meet her needs. By working with Mary’s existing so-
cial resources (both lay and professional) this facilitator
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Table 2 Baseline characteristics of patients with Heart Failure participating in the Process Evaluation
Characteristic REACH-HF
n = 107 (%)
Qualitative interview sample
n = 19 (%)
Age (years), mean (SD) 69.7 (10.9) 68.5 (9.8)
Female sex 26 (24) 7 (37)
BMI (kg/m2); mean (SD) 29.5 (6.6) 31.5 (7.4)
Main activity
Retired 81 (76) 15 (79)
In employment or self-employment 18 (17) 2 (11)
Unemployed 5 (5) 1 (5)
Other 3 (3) 1 (5)
Ethnic origin
White 100 (93) 19 (100)
Other (Black, Asian, other) 7 (7) 0 (0)
NYHA status
Class I 24 (22) 0 (0)
Class II 63 (59) 13 (68)
Class III 20 (19) 6 (32)
Ischaemic aetiology of HF 48 (45) 9 (47)
Time since diagnosis of HF (years)
< 1 35 (33) 6 (32)
1–2 18 (17) 1 (5)
> 2 54 (51) 12 (63)
LVEF (%); mean (SD), n 32 (8), 76 27 (9), 11
NT-pro-BNP level (pg/mL); mean (SD) 1460 (1928) 1321 (1123)
Current smoker 6 (6) 1 (5)
Comorbidities (past or present)
Diabetes mellitus 26 (24) 5 (26)
Myocardial infarction 29 (27) 7 (37)
Hypertension 45 (42) 9 (47)
Chronic renal impairment 14 (13) 3 (16)
Arthritis (osteoarthritis or rheumatoid) 45 (42) 11 (58)
Atrial fibrillation or atrial flutter 48 (45) 9 (47)
COPD 9 (8) 2 (11)
Depression 27 (25) 7 (37)
Number of comorbidities
0 63 (59) 9 (47)
1 32 (30) 7 (37)
2 7 (7) 1 (5)
3 5 (5) 2 (11)
Baseline use of drugs
Beta-blocker 90 (84) 18 (5)
Angiotensin II receptor antagonist 31 (29) 8 (42)
ACE inhibitor 68 (64) 10 (53)
Baseline use of devices
ICD 10 (9) 3 (16)
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enabled self-care practices (e.g., walking) and social sup-
port systems to develop, which changed the meaning
that Mary attributed to living with heart failure and en-
hanced her coping competencies.
Good fidelity and poor tailoring
While the intervention was tailored to Mary’s needs with
good effect, John’s enduring socio-economic circum-
stances inhibited the effectiveness of the intervention.
John is a 71 year old divorced man with depression, who
smokes cigarettes and was diagnosed with heart failure 6
months previously. Living alone in a privately rented
first-floor flat, but about to move into ground-floor so-
cial housing, he was troubled by large debts to utility
companies. Despite suggesting that he had lived with
heart failure since having rheumatic fever at 8 years old,
John demonstrated that he did not understand how his
heart worked to support activity.
Although the facilitator took a medical history and in-
troduced the elements of the intervention, John spent
much time talking about his stressful financial situation.
Running out of time, the facilitator was unable to get be-
yond John’s social problems and did not elicit a self-care
goal from John to underpin his rehabilitation. Thereafter
the conversation remained facilitator-led, with little evi-
dence of rapport building. Instead the overarching con-
cern remained debt and over time tailoring was
diminished as the facilitator adopted a more didactic
Table 2 Baseline characteristics of patients with Heart Failure participating in the Process Evaluation (Continued)
Characteristic REACH-HF
n = 107 (%)
Qualitative interview sample
n = 19 (%)
CRT 10 (9) 1 (5)
Combined CRT/ICD 5 (5) 2 (11)
Pacemaker 11 (10) 1 (5)
Location
Cornwall 30 (28) 7 (37)
Gwent 23 (22) 3 (16)
Birmingham 27 (25) 4 (21)
York 27 (25) 5 (26)
Caregiver present at randomisation 53 (50) 13 (68)
Table 3 Illustrative cases: Baseline Data
Good tailoring Poor tailoring
Good fidelity Mary
74 year old female
Retired, non-smoker
HF for 3 years
Comorbid breast cancer, arthritis, chronic back
pain, vaginal prolapse
Medications: A2 receptor agonist, beta-blocker,
loop diureticNYHA Class II (Mild)
Ejection fraction Severe (< 35%)
HADS Anxiety (1) Depression (2)
MLHFQ (50)
Lives with husband in redeveloped semi-detached
council house.
Cared for by her 3 daughters.
John
71 year old male
Retired, smoker
HF for 6 months
Comorbid chronic back pain and depression.
Medications: ACE Inhibitor, Aldosterone receptor
agonist, beta-blocker, loop diureticNYHA Class II (Mild)
Ejection fraction Severe (< 35%)
HADS Anxiety (7) Depression (9)
MLHFQ (50)
Lives alone (divorced) in privately rented first floor flat,
waiting to be rehoused in social housing.
Daughter visits, but not designated carer.
Poor fidelity Helen
68 year old female
Retired, ex-smoker
HF for 7 months
Comorbid lung cancer, arthritis, back pain depression
Medications: A2 receptor agonist, beta-blocker, loop diuretic
NYHA Class III (Moderate)
Ejection fraction Severe (< 35%)
HADS Anxiety (19) Depression (11)
MLHFQ (Missing) Lives with husband (also her carer) in
privately owned bungalow, built by her husband
Dorothy
73 year old female
Retired, non-smoker
HF for 6 months
No comorbid conditions
Medications: ACE Inhibitor, Aldosterone receptor
agonist, beta-blocker, loop diuretic NYHA Class II (Mild)
Ejection fraction Severe (< 35%)
HADS Anxiety (4) Depression (2)
MLHFQ (Missing)
Lives alone (widowed) in privately owned semi-
detached house.
Cares for her grandchildren.
These four illustrative cases demonstrate the interplay between materials, meanings and competencies. Names are pseudonyms
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Table 4 Typology of Fidelity and Tailoring: Longitudinal data
Good tailoring Poor tailoring
Good fidelity Mary
Facilitator Baseline notes: “Realises that she is not exercising
much but is active all day. Would like to walk but is limited
by [vaginal] prolapse, limited by backache (osteopenia) and
osteoarthritis … Occasional walk around shopping centre
or park with daughter. Nervous to go alone. (daughters)
very supportive and keen to understand and help”
(Facilitator 1, initial contact sheet)
Facilitator baseline assessment:
Facilitator: Is there anything else at the moment that you
want to talk about to do with your heart condition?
Mary: when they say like with the heart is weak or heart
failure part I mean, that, what is, that means the heart is
weaker?
Facilitator: yes the heart muscle it has been damaged…or
become stretched you know and isn’t, when the muscles
contract, whether it’s your arm muscle or your leg muscle
or your heart muscle, it sort of contracts and squeezes…yes
that’s right and it’s not squeezing quite as much as it should
do, so not quite so much blood is actually getting circulated
each time. So the reason why you get breathless is because
your heart is not pumping enough blood and oxygen
around the body. So your breathing is a sort of automatic
reaction for it…. (Facilitator 1 Initial assessment)
Patient interview at 4 months:
“when [facilitator] was there she never rushed us, we’d go
through things steadily page by page on the book I was
writing on…Progress Tracker....she spent the time and
she explained things and I found it very good. She also
just let me chat about what benefits I was finding from
it” (Mary 4 month interview)
Patient interview at 12 months:
“the knowledge I gained from [facilitator], the information,
the questions that I asked right at the beginning…were
probably some of the most important ones….she was
able to not just answer it but explain it as well…I’m a
person that is, if you want to tell me something, tell me
so that I can understand it…but if it’s also written down,
I can also get more knowledge…often more than just
talking about it, ‘cos you take it in just a bit at a time”
(Mary 12 month interview)
Facilitator mid-intervention contact sheet:
“Phoned to check on progress. However she was in bed
with a very bad [urinary tract infection]. Seen by GP and
on antibiotics. Told to drink plenty of water. She was
unsure what to do as limited to 1 l [due to severity of HF].
Advised that the GP would know that she is restricted yet
has advised the extra drinks to flush thro’ the infection. If
she’s worried she should contact the GP or [HFCNS]…”
(Facilitator 1, subsequent contact sheet)
Patient interview at 4 months:
“I have sometimes to draw my breath in because they
[my daughters] smother me…the surgeon that put the
stent in my heart… he told my daughters and my
husband:” “I’ve only done one part, the rest of it is
medication to help support your heart. Your heart is
very, very weak… I never clocked that they were so
worried” (Mary 4 month interview)
Patient interview at 12 months:
“I’m very pleased with how I’ve got on since I started this
[programme]… as I was looking at life before then, that
this is how I was going to be, spending most of my time
in the chair, and looking at the place going:” “Oh I wish I
could do this, I wish that I could do that, and now I don’t
wish…there’s a total difference to me to what there was”
(Mary 12 month interview)
John
Facilitator Baseline notes: “First home visit – introduction to the
manual- Discussed patient’s understanding of HF manual and
information given as to the purpose of my visits – History taken
from patient – social support discussed. Issues around housing
discussed…signposted to the manual” (Facilitator 2, initial
contact sheet)
Facilitator final notes:
“Home circumstances big concern for [John], listened to [John]‘s
concerns with landlord/electric/gas/rehousing. Awaiting rehousing
[John] has all the relevant contact numbers... Discussed how I felt
[John] had benefited from manual – better understanding of heart
failure, medications, signs and symptoms etc.” (Facilitator 2, final
contact sheet)
Patient interview at 4 months:
“I don’t think it put a lot of my mood in [Progress Tracker] I’d’ve
put good every time...the biggest problem I’ve had is with the
gas board. I did put shopping, hobbies as well...The biggest
difference is when I’m going to move into this bungalow, I
mean I’m a smoker, I have cut down a hell of a lot...It’s a no
smoking area” [John, 4 month interview]
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style. Towards the end of this initial assessment session,
the facilitator drew on her professional repertoire and
provided John with a plumbing metaphor to explain
how his cardiovascular system works, but while she pro-
ceeded with her explanation John said “you’re rattling on
now” and she did not tailor the session to his response.
This is reflected in the facilitator notes for this session
which detailed her interpretation of the session rather
than John’s.
Throughout the intervention period John continued to
record his mood as ‘good’ in the Progress Tracker des-
pite his enduring problems, and he provided minimal
details about his exercise and medication use, other than
noting that he gained weight. John subsequently
withdrew from the randomised controlled trial and
process evaluation, but the focus when interviewed at 4
months was about a perceived better future, rather than
present, and his motivation for cutting down smoking
was due to planned accommodation changes, rather
than any new meaning attributed to REACH-HF.
While Mary’s facilitator engaged Mary’s existing sup-
port network to supplement her behaviour change, John
has little social or material capital to draw on. His
underlying depression and perception of his current cir-
cumstances are such that he is unable to engage with
the new material and competencies that REACH-HF
provide in a way that would enable him to construct a
new meaning or self-care practices around his heart
Table 4 Typology of Fidelity and Tailoring: Longitudinal data (Continued)
Good tailoring Poor tailoring
Poor fidelity Helen
Facilitator initial contact: “How she was – emotional.
Very anxious about condition. Scared she might
die suddenly...Explored support from [local agency]
and areas of manual to try techniques to relieve
stressful symptoms...” (Facilitator 3, initial contact
sheet)
Patient interview at 4 months:
“I was really getting very depressed...I’m just heaps
better than before...And if it wasn’t for being on
the [REACH-HF] study, I don’t think I’d be walking
like I am now.” (Helen, 4 month interview)
“Interviewer: Did you show the manual to anybody
else?Helen: No, I hid it in a drawer. I didn’t want the
children to see it...and then I got to the CPR bit...I
didn’t want the children to know that something
could happen to me suddenly... when they were
gone I’d take it out, because I had to remember to
write my daily strides in it.” (Helen, 4 month interview)
Patient interview at 12 months:
“Interviewer: Have you gone back [to the manual]?
Helen: No, I’m sorry, every time I pick up the manual
I see the terminal bit of it, so I haven’t... when I read
things like that...I tend to add a little bit, or read
things into it. My brain goes: zoom, to the point of
no return.” (Helen, 12 month interview)
By failing to increase her knowledge and
understanding about HF, Helen learned by rote
and was very proud of recording her 1900 steps a
day in the Progress Tracker, which reflected the
focus of the facilitated sessions:
Patient interview at 4 months:
“[Facilitator] said: it’ll build your heart muscle up... I
wasn’t thinking that way, I was thinking: If I rest my
heart and don’t do anything...keep me going a bit
longer... And the more I thought about walking,
and my heart muscle and all, the more, well, I
thought: Well, I’ll walk and try and get stronger”
(Helen, 4 month interview)
Facilitator final contact sheet:
“How’s she feeling – good about her heart.
Worried about lung. Good days but more bad
days. Previously not answering phone. Feeling a
little brighter now...Weight decreased. Not eating.
Discussed nutritional drinks from GP. Doesn’t want
to contact GP. Not renewed prescription for
Valium...Me to contact GP re: nutritional drinks and
Valium” (Facilitator 3, final contact sheet)
Dorothy
Facilitator initial contact sheet:
“Introduction to REACH, myself
and manuals. Discussion surrounding
use of Progress Tracker, traffic light
system and signs and symptoms....”
(Facilitator 4, initial contact sheet)
Facilitator initial assessment:
Facilitator: and what did [Doctor] say about this scan?
Dorothy: he was (sighs) do you know what, I do find it
confusing. He said something about 40%
F: OK
D: is that 40% not working or 40% working?
F: yes, OK
D: I’m not sure which way that went
F: Ok yeah, I’m not sure about whether it is 40% but if … my
suspicions are if you say 40%, is that yes that it’s working (pause)
at 40% of what’s expected, if that makes sense. (Facilitator
4 Initial assessment)
Patient interview at 4 months:
“Interviewer: Did you try the chair based exercises?”
Dorothy: I didn’t, not really. No I didn’t... Sorry [laughter]....I
didn’t find it comfortable...
I didn’t tend to wear the [pedometer] and when it fell off, I didn’t
seem to carry on with it...
Interviewer: Are you sort of writing things down anywhere,
or monitoring?
Dorothy: Oh, now I’ve got to be honest: No I haven’t done, no....the
manual tend to just flick through and just read different pages you
land on …
“Interviewer: Was there anything that you didn’t like [about the
facilitator], I’m sensing that you’re a little bit reserved?
Dorothy: Didn’t seem reliable...I just felt it wasn’t constant.”
(Dorothy 4 month interview).
Patient interview at 12 months:
“I still can’t see myself as a priority...I can’t seem to get the
seriousness of it...I seemed to think that because I was busy, I’m
exercising but it’s not, it’s not the same thing really is it? I haven’t
kept up [with the monitoring]...I did have a diary at first...No, have
got a bit complacent...I don’t know what to look for really... my
condition hasn’t changed...” (Dorothy 12month interview)
Frost et al. BMC Medical Research Methodology          (2020) 20:181 Page 9 of 14
failure. Although the facilitator fully acknowledged his
distressing circumstances neither her existing competen-
cies nor the intervention materials could be tailored to
mitigate such extensive socio-economic deprivation.
Poor fidelity and good tailoring
Sixty-eight year old Helen received one of the highest
doses of REACH- HF at 470 min, over 4 face-to-face and
7 telephone sessions with her facilitator. She was re-
cently diagnosed with heart failure and a lung ‘nodule’,
and has long standing anxiety and depression, with some
of the highest HADS scores (Anxiety = 19, Depression =
11) in the wider trial population at baseline. Helen lives
with her husband who is her caregiver, but who struggles
to deal with her emotional state. Unlike John, Helen had
many interactions with multiple health professionals in
the 6months prior to the trial. Helen’s facilitator began by
dealing with Helen’s concerns head-on: unpacking her fear
of dying. This is one of the few cases in which the facilita-
tor demonstrated the required exercise level to the patient,
by actively walking with her and demonstrating warming
up, cooling down, and the required effort for exercising
the heart, which Helen valued.
However, while Helen was happy to do the physical
exercise that the facilitator suggested, she did not fully
engage with the heart failure manual – hiding it from
her family and ignoring the sections which would have
increased her own learning about the severity of her
condition. By failing to increase her knowledge and un-
derstanding about heart failure, Helen learned by rote
and was very proud of recording her 1900 steps a day in
the Progress Tracker, which reflected the focus of the fa-
cilitated sessions.
While improving her exercise capacity was beneficial,
this was in the absence of wider learning about her con-
dition which meant that over time 1900 steps became
the end rather than the means of improving her quality
of life. The facilitator was viewed as kind and caring, but
this was to the detriment of challenging Helen’s fears or
supporting her autonomy. The subsequent sessions were
increasingly didactic, as the facilitator failed to elicit the
required response from Helen and instead made as-
sumptions on her behalf. For example in the second
audio-recorded session the facilitator asked Helen what
her priorities were, but failed to wait for Helen’s reply.
Subsequently other missed opportunities for engagement
included not reviewing Helen’s physical symptoms and
only using the heart failure manual in a responsive way,
so that relevant sections were repeatedly omitted. In the
final audio-recorded session the facilitator did not check
Helen’s understanding of heart failure or explore why
she had not contacted a local agency; rather the facilita-
tor took on the task of arranging appointments and
medication.
Helen achieved a limited transformation as a result of
her involvement in REACH-HF. While the facilitator
demonstrated a degree of competence in modelling the
required exercise, Helen assumed that the circuit that
they covered was sufficient and there was limited use of
additional REACH-HF materials. Helen learned that her
heart needed to be exercised, but this was achieved via
habitual repetition rather than any increased compe-
tence or new meaning that would have allowed Helen to
tailor her exercise to the weather or extend it to improve
her mental health. Furthermore, many of her existing
behaviours around denial and lack of agency went
unchallenged.
Poor fidelity and poor tailoring
The final case is Dorothy, a 73 year old widow who lives
alone and often looks after her grandchildren. She was
diagnosed with heart disease 6months before the trial,
and while struggling to come to terms with her diagnosis
was one of the sickest patients in the process evaluation,
with an ejection fraction of only 21% at baseline cardiac
assessment.
This example is striking for what was absent. The
audio-recording of the initial session began with the
introduction of the REACH-HF manual, and there was
no discussion of Dorothy’s medical history, goals, or so-
cial situation. Here, fidelity scores were low at baseline
and subsequently (all under 2.5 and deemed inadequate).
The facilitator neither elicited or addressed Dorothy’s
concerns despite her being newly diagnosed, having seen
no health professionals since diagnosis, and having a
limited understanding of her condition.
This also seems to be an example of lack of profes-
sional competence, as the facilitator was unable to an-
swer adequately a straightforward question about
Dorothy’s heart failure. While Dorothy had little under-
standing of her heart failure, the facilitator lacked the
competence to improve her learning, as demonstrated in
a subsequent session when Dorothy asked a question
about medication and the facilitator neither found the
relevant section in the manual nor drew upon any wider
professional knowledge. Because the facilitator continu-
ally failed to engage Dorothy in the programme, Dorothy
gained little understanding of the utility of the trial ma-
terials, and suggested that she had little faith in the facil-
itator’s competence. Post- intervention Dorothy was still
struggling to reconcile that she had a chronic condition
that requires self-care. She admitted that she would let
her weight increase by seven to fourteen pounds (poten-
tially fatal) before she would call for professional help.
Dorothy lacked the skills and competence to care for
her heart failure, and having a facilitator who failed to
challenge her existing interpretations ensured that Doro-
thy did not engage with the REACH- HF intervention.
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Like Helen, Dorothy now has a walk that she undertakes
regularly, but she has been unable to develop any mean-
ingful notion of her heart failure, as she still attributes
her lack of deterioration to the lack of severity of her
heart failure, whereas paradoxically any subsequent de-
terioration would be attributed to “just my age”.
Discussion
Summary of key findings
This is the first process evaluation of an evidence-based
home-based rehabilitation intervention to optimise self-
care support for heart failure patients and their care-
givers. We identified that the intervention was most ef-
fective when fidelity was high and delivery was tailored
to the individual’s needs, and that the intervention was
less effective when both tailoring and fidelity were low.
Furthermore, our theory-based analysis enabled us to
model complex relationships between intervention ele-
ments (competencies, materials and meanings) and so-
cial context. For example, in our ‘best case’ the meaning
that Mary attributed to living with heart failure was
transformed by the strategic use of professional compe-
tencies (skilled goal elicitation), purposeful use of mate-
rials (the tailored use of the manual and progress
tracker), and the augmentation of meanings (through
the continued engagement and support of Mary and her
family). Whereas, in our ‘worst case’ Dorothy’s meaning
was not transformed because neither the competencies
of the facilitator (both heart failure specific and wider
professional knowledge) or materials (which were not
tailored to needs) were able to engage her in the
programme. By using Social Practice Theory to interro-
gate these relationships between the various elements of
the intervention over time we were able to identify how
fidelity and tailoring are contextual and how effective-
ness of the REACH-HF intervention was dependent on
both optimal alignment and implementation of ele-
ments. Therefore Social Practice Theory not only pro-
gressed our understanding of both the findings and
processes of a trial of a clinical intervention but also pro-
vided insights to inform the development of strategies
for implementation in routine practice [20, 47].
Interpretation and implications of results
The constituents of the REACH-HF intervention were
chosen in response to the challenges of implementing a
rehabilitation intervention within the patient’s home
[48], based on empirical evidence of their effectiveness,
and engagement with stakeholders [31]. While theoretic-
ally informed qualitative analyses have previously identi-
fied the importance of self-care ‘assemblages’ in routine
practice [49, 50], we sought to explore the dynamic in-
teractions of fidelity and tailoring during the delivery of
the REACH-HF intervention under trial conditions and
subsequently to inform implementation strategies.
By utilising a theory-based mixed methods approach,
we were able to identify key practices (such as the health
professional knowing when to employ appropriate sec-
tions of the manual or implement practices from their
wider professional repertoire) as well as configurations
of best practice (such as the facilitator demonstrating
the required exercise level and tailoring explanations).
These demonstrate that persistence and change are
dependent upon feedback between one instance or mo-
ment of enactment and another, and on patterns of mu-
tual influence between co-existing practices [11].
Our findings indicate that the opportunities for achiev-
ing sustained behaviour change are contingent upon
what the bundles of intervention practices demand of a
person with heart failure and/or their caregiver and on
previous life histories and resources accumulated along
the way. This suggest that the provision of a simple
blueprint or template for implementation into routine
practice would be inappropriate considering the potential
importance of tailoring the intervention to context and
any change over time. Rather than a generalisable pre-
scription our mixed methods approach provides critical
transferable insights and greater explanatory power, allow-
ing policy makers and practitioners (both lay and profes-
sional) to make informed decisions about future uptake of
individual elements, bundles of elements, and the total
REACH-HF package more generally [15, 43, 51, 52].
Our findings highlight the importance of one-to-one
contact for participants. Thus, although such contact
may be expensive, it may be critical to allow flexibility to
ensure intervention impact across participants. Our find-
ings also highlight how intervention delivery can vary
across personal contexts, so emphasising the need to
identify and train facilitators for best practice in inter-
vention delivery before implementation. Our findings
emphasise the value of both a Hybrid Type 1 trial design
- synthesising randomised controlled trial and process
evaluation data - prior to implementation. The integra-
tion of process and outcome data over time enabled us
to make within-case and cross-case analyses. Such com-
parisons can highlight how well an intervention is de-
signed to respond to a range of participant needs. This
may direct intervention improvement prior to imple-
mentation (e.g. more focused facilitator training), as well
as future implementation strategies (e.g. that align as-
sessment of contextual factors, identification of patient
and clinical goals, and the most appropriate intervention
components).
Implications for research
This paper has a number of implications for future re-
search. Commentators note that theoretical endeavours
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for implementation science often lack “how-to” support
for carrying out implementation evaluation and inter-
pretation [53]; can overlook the extent to which practi-
tioners determine the processes and outcomes of
implementation [54]; and the extent to which context is
wider than the physical setting in which the implementa-
tion takes place [16, 17].
Social Practice Theory enabled us to identify that this
complex behaviour change intervention was optimised
when the competencies of the facilitator (e.g. rigorous
assessment and an ability to challenge lay interpreta-
tions) and the intervention materials (e.g. the section of
a manual or use of a patient tracker) were tailored to the
goals and needs of the participant in ways which enabled
them to transform the meaning (e.g. foster an appreci-
ation of the value of exercise), thus enabling them to de-
velop sustainable and flexible self-management practices.
Sometimes, this was achieved despite a participant’s en-
during problems; but not all facilitators were well
acquainted with the intervention, or knowledgeable
enough to deliver it well. If the problem is within the
scope of the intervention (e.g. anxiety) then the tailoring
is appropriate although fidelity may be compromised.
However, if the problem is not within the scope of the
intervention (e.g. material deprivation), then tailoring is
very difficult. Our attention must now turn to how to
deliberately steer or target practices and/or bundles of
practices in the face of enduring health care and struc-
tural inequalities.
Hawe et al. contend that perhaps one of the reasons
for interventions not working is that their components
have been overly standardised, proposing that thinking
about the real world context should become the ideal in-
stead [14]. Our findings suggest that Social Practice The-
ory provides a framework for us to bring the social
context back into process evaluations of complex inter-
ventions to inform implementation strategies in a mean-
ingful way [14, 23].
We agree with Blue et al. [50] that complex interven-
tions need to move beyond seeing people as static indi-
vidual selves that require changing, to engaging people
entwined in dynamic social arrangements who are de-
fined and constituted through the practices that they
adopt and enact [23]. We suggest that our use of Social
Practice Theory to inform our analysis of multi-modal
process and outcome data is a robust and dynamic the-
oretically informed methodological approach for evaluat-
ing intervention and implementation practices. We see
this as having the potential to illuminate which configu-
rations of elements need to be customised for every
‘user’ - such that any standardisation concerns the func-
tion of elements or bundles of elements that constitute
interventions in a given context (e.g. unpacking Helen’s
anxieties about death to enable her to participate in
exercise), rather than the current focus on standardising
the form of elements and their delivery (e.g. the deploy-
ment of the manual in Dorothy’s case without wider
contextualisation) [55]. We suggest that this can help us
moved toward the implementation of personalised inter-
ventions at scale [29].
Strengths and limitations
We have conducted the first mixed methods process eval-
uations of a comprehensive self-management intervention
for people with heart failure and their carers. The use of a
well specified sociological theory (Social Practice Theory)
enabled the core elements of this complex intervention
and their assemblages to be better articulated, explored
and explained. This has enabled us to amplify the quanti-
tative trial results and to use these insights to develop our
subsequent implementation strategy.
We have acknowledged the limitations of this study
elsewhere, in relation to other data we might have col-
lected [32]. Our ongoing research and implementation
activities aim to redress some of these limitations and
build on our findings, with particular reference to the
training and support of the facilitators [56, 57]. We have
also noted the lack of diversity of our patient population,
and it is also vital to address the particular challenges fa-
cing people from black and minority ethnic communities
who are not well served by current interventions.
Conclusion
We conclude that Social Practice Theory has the poten-
tial to progress our understanding from a trial of a clin-
ical intervention at T2 (translation to patients), to guide
the development of an intervention strategy for imple-
mentation at T3 (translation to practice) via the identifi-
cation of the most appropriate configurations of bundles
of intervention elements for implementation in individ-
ual real-world clinical scenarios.
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